Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES)

European Journal of Epidemiology

Volumn 29, Issue 12, 2014, Pages 887-897

  O’Doherty, Mark G ^a   Jørgensen, Torben ^b   Borglykke, Anders ^b   Brenner, Hermann ^c   Schöttker, Ben ^c   Wilsgaard, Tom ^f   Siganos, Galatios ^f   Kavousi, Maryam ^g   Hughes, Maria ^a   Müezzinler, Aysel ^c,d   Holleczek, Bernd ^e   Franco, Oscar H ^g   Hofman, Albert ^g   Boffetta, Paolo ^h,i   Trichopoulou, Antonia ^i,j   Kee, Frank ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e SAARLAND CANCER REGISTRY   (Germany)

^f UNIVERSITY OF TROMSØ   (Norway)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

more..

Author keywords

Ageing; C reactive protein; Cardiovascular disease; CHANCES; Mortality; Obesity

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; UNITED STATES; AGED; CAUSE OF DEATH; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOCIOECONOMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84922104277     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9954-8     Document Type: Article

References (63)

1. World Health Organization. Fact sheet No.311, Obesity and overweight. World Health Organization. 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 1 May 2014.
2. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71–82.
3. Borrell LN, Samuel L. Body mass index categories and mortality risk in US Adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104:512–9.
4. Wang Z. Age and the impact of obesity on mortality. Am J Public Health. 2014;104:e3.
5. Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103:1895–901.
6. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.
7. Schelbert KB. Comorbidities of obesity. Prim Care. 2009;36:271–85.
8. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010;18:377–83.
9. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010;363: 2211–9.
10. Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301–13.
11. World Health Organization. Fact sheet No.317, Cardiovascular diseases (CVDs). World Health Organization. 2013. http//www.who.int/mediacentre/factsheets/fs317/en/. Accessed 16 July 2014.
12. Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013;2013:678159.
13. Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart. 2008;94:457–62.
14. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.
15. Giovannini S, Onder G, Liperoti R, Russo A, Carter C, Capoluongo E, et al. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc. 2011;59:1679–85.
16. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol. 1985;27:83–111.
17. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis. 1999;145:375–9.
18. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087–91.
19. Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31:2092–6.
20. Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? Circulation. 2009;120:2036–9.
21. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367:1310–20.
22. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J. 2010;31:1624–32.
23. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–97.
24. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264:295–314.
25. Zheng H, Tumin D, Qian Z. Obesity and mortality risk: new findings from body mass index trajectories. Am J Epidemiol. 2013;178:1591–9.
26. Somes GW, Kritchevsky SB, Shorr RI, Pahor M, Applegate WB. Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program. Am J Epidemiol. 2002;156:132–8.
27. Reas DL, Nygård JF, Svensson E, Sørensen T, Sandanger I. Changes in body mass index by age, gender, and socio-economic status among a cohort of Norwegian men and women (1990–2001). BMC Public Health. 2007;7:269.
28. Claessen H, Brenner H, Drath C, Arndt V. Repeated measures of body mass index and risk of health related outcomes. Eur J Epidemiol. 2012;27:215–24.
29. Osler M, Linneberg A, Glümer C, Jørgensen T. The cohorts at the Research Centre for Prevention and Health, formerly “The Glostrup Population Studies”. Int J Epidemiol. 2011;40:602–10.
30. Schöttker B, Müller H, Rothenbacher D, Brenner H. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia. 2013;56:92–100.
31. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41:961–7.
32. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889–926.
33. Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hervonen A, Jylhä M. Body mass index, waist circumference, and waist-to-hip ratio as predictors of mortality in nonagenarians: the Vitality 90+ Study. J Gerontol A Biol Sci Med Sci. 2011;66:1244–50.
34. Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TIL, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One. 2011;6:e26621.
35. Cohen SS, Signorello LB, Cope EL, McLaughlin JK, Hargreaves MK, Zheng W, et al. Obesity and all-cause mortality among black adults and white adults. Am J Epidemiol. 2012;176:431–42.
36. Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, et al. Body mass index and survival in men and women aged 70–75. J Am Geriatr Soc. 2010;58:234–41.
37. Mikkelsen KL, Heitmann BL, Keiding N, Sørensen TI. Independent effects of stable and changing body weight on total mortality. Epidemiology. 1999;10:671–8.
38. He J, McGee D, Niu X, Choi W. Examining the dynamic association of BMI and mortality in the Framingham Heart Study. Int J Environ Res Public Health. 2009;6:3115–26.
39. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.
40. Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30:2584–92.
41. Hastie CE, Padmanabhan S, Slack R, Pell ACH, Oldroyd KG, Flapan AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222–6.
42. Auyeung TW, Lee JSW, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese–a 5-year follow-up study in 4,000 older adults using DXA. J Gerontol A Biol Sci Med Sci. 2010;65:99–104.
43. De Hollander EL, Bemelmans WJ, Boshuizen HC, Friedrich N, Wallaschofski H, Guallar-Castillón P, et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol. 2012;41:805–17.
44. Nakajima K, Yamaoka H, Morita K, Ebata M, Eguchi S, Muneyuki T, et al. Elderly people with low body weight may have subtle low-grade inflammation. Obesity (Silver Spring). 2009;17:803–8.
45. Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2010;65:377–81.
46. Lee H, Lee IS, Choue R. Obesity, Inflammation and Diet. Pediatr Gastroenterol Hepatol Nutr. 2013;16:143–52.
47. Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.
48. Blüher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes. 2012;19:341–6.
49. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99:462–8.
50. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758–69.
51. Hill JO, Wyatt HR. The myth of healthy obesity. Ann Intern Med. American College of Physicians; 2013;159: 789–90.
52. Beleigoli AM, Boersma E, de Diniz M, FH Vidigal PG, Lima-Costa MF, Ribeiro AL. C-reactive protein and B-type natriuretic Peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults. PLoS One. 2013;8:e75809.
53. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.
54. Doran B, Zhu W, Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J. 2013;166:45–51.
55. Gupta NK, de Lemos JA, Ayers CR, Abdullah SM, McGuire DK, Khera A. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study. J Am Coll Cardiol. 2012;60:1148–55.
56. Chapman MJ, Giral P, Barter PJ. The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER. Eur Heart J. 2013;34:1318–20.
57. Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, et al. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013;178:1076–84.
58. Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–25.
59. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. 34th Bethesda Conference: task force #1–Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41:1863–74.
60. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–99.
61. He Y. Missing data analysis using multiple imputation: getting to the heart of the matter. Circ Cardiovasc Qual Outcomes. 2010;3:98–105.
62. Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197–209.
63. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29:1011–29.